Increased CD133+CD34+VEGFR-2+ endothelial precursor cells (EPCs) are detectable in the peripheral blood of patients with aggressive lymphomas and decrease in number following complete response to chemotherapy [40]. Here, PROM1 is linked to lymphoma.